Tag Archives: Vaccine

FDA authorizes Pfizer’s coronavirus vaccine for younger teens

Dive Brief: The Food and Drug Administration on Monday cleared Pfizer’s coronavirus vaccine for emergency use in children 12 to 15 years old, making the shot the first authorized for millions of younger adolescents in the U.S. The agency’s decision, which had been expected since Pfizer and partner BioNTech asked in early April for an expansion of… Read More »

FDA expands Pfizer vaccine authorization to include teenagers ages 12 to 15

The Food and Drug Administration authorized the Pfizer-BioNTech coronavirus vaccine to be used in teenagers ages 12 to 15, making it the first to be deemed safe for people under 16. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to… Read More »

NIH ‘very concerned’ about serious side effect in AstraZeneca coronavirus vaccine trial

“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal… Read More »

High-tech problem for Joe Biden’s COVID vaccine patent waiver

The difficulty of learning the technology behind mRNA vaccines poses a major obstacle to President Joe Biden’s proposal aiding poor countries by defying the pharmaceutical industry and waiving patent protections for COVID-19 vaccines. The rationale for the patent waiver would be to allow developing countries to reproduce currently existing COVID-19 vaccines without having to worry… Read More »

Pharma erupts as Biden administration backs waiver of vaccine patent rights

The Biden administration’s call to waive patent rights for coronavirus vaccines sparked vociferous opposition from drugmakers and pharma industry groups, which quickly claimed the move will discourage future drug research and do little to increase supply.  Activists, who have pressured the administration for months on the issue, argue a waiver is needed to begin removing… Read More »